Annual Accounts Payable
$1.32 M
-$307.10 K-18.89%
December 31, 2023
Summary
- As of February 12, 2025, GANX annual accounts payable is $1.32 million, with the most recent change of -$307.10 thousand (-18.89%) on December 31, 2023.
- During the last 3 years, GANX annual accounts payable has risen by +$357.50 thousand (+37.18%).
- GANX annual accounts payable is now -18.89% below its all-time high of $1.63 million, reached on December 31, 2022.
Performance
GANX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.10 M
-$948.30 K-46.33%
September 30, 2024
Summary
- As of February 12, 2025, GANX quarterly accounts payable is $1.10 million, with the most recent change of -$948.30 thousand (-46.33%) on September 30, 2024.
- Over the past year, GANX quarterly accounts payable has dropped by -$220.50 thousand (-16.72%).
- GANX quarterly accounts payable is now -50.37% below its all-time high of $2.21 million, reached on March 31, 2023.
Performance
GANX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
GANX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.9% | -16.7% |
| 3 y3 years | +37.2% | +96.0% |
| 5 y5 years | - | +96.0% |
GANX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.9% | +135.3% | -50.4% | +96.0% |
| 5 y | 5-year | -18.9% | +754.3% | -50.4% | +96.0% |
| alltime | all time | -18.9% | +754.3% | -50.4% | +96.0% |
Gain Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.10 M(-46.3%) |
| Jun 2024 | - | $2.05 M(+45.7%) |
| Mar 2024 | - | $1.41 M(+6.5%) |
| Dec 2023 | $1.32 M(-18.9%) | $1.32 M(-4.2%) |
| Sep 2023 | - | $1.38 M(+49.0%) |
| Jun 2023 | - | $924.40 K(-58.2%) |
| Mar 2023 | - | $2.21 M(+36.1%) |
| Dec 2022 | $1.63 M | $1.63 M(+59.6%) |
| Sep 2022 | - | $1.02 M(+7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $948.90 K(-55.2%) |
| Mar 2022 | - | $2.12 M(+277.9%) |
| Dec 2021 | $560.50 K(-41.7%) | - |
| Dec 2021 | - | $560.50 K(-29.0%) |
| Sep 2021 | - | $789.40 K(-19.3%) |
| Jun 2021 | - | $978.40 K(+11.0%) |
| Mar 2021 | - | $881.80 K(-8.3%) |
| Dec 2020 | $961.50 K(+522.7%) | - |
| Dec 2020 | - | $961.50 K |
| Dec 2019 | $154.40 K | - |
FAQ
- What is Gain Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Gain Therapeutics?
- What is Gain Therapeutics annual accounts payable year-on-year change?
- What is Gain Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Gain Therapeutics?
- What is Gain Therapeutics quarterly accounts payable year-on-year change?
What is Gain Therapeutics annual accounts payable?
The current annual accounts payable of GANX is $1.32 M
What is the all time high annual accounts payable for Gain Therapeutics?
Gain Therapeutics all-time high annual accounts payable is $1.63 M
What is Gain Therapeutics annual accounts payable year-on-year change?
Over the past year, GANX annual accounts payable has changed by -$307.10 K (-18.89%)
What is Gain Therapeutics quarterly accounts payable?
The current quarterly accounts payable of GANX is $1.10 M
What is the all time high quarterly accounts payable for Gain Therapeutics?
Gain Therapeutics all-time high quarterly accounts payable is $2.21 M
What is Gain Therapeutics quarterly accounts payable year-on-year change?
Over the past year, GANX quarterly accounts payable has changed by -$220.50 K (-16.72%)